FDA Issues Warnings about False Cancer Cure Claims
The U.S. Food and Drug Administration (FDA) has issued warning letters to four companies for illegally selling products online that claim to prevent, diagnose, treat, or cure cancer without evidence to support these outcomes. This action is part of the FDA’s continued efforts to protect consumers from health fraud.
Selling unapproved products that have not been shown to be safe or effective is a violation of the Federal Food, Drug and Cosmetic Act. It also puts patients at risk and may prevent them from seeking appropriate, recognized therapies to treat serious, potentially fatal, diseases like cancer.
The four companies warned by the FDA illegally sold products allegedly containing cannabidiol (CBD), a component of marijuana plants that is not FDA approved for any indication. CBD is marketed in a variety of products, including capsules, oil drops, syrups, teas, and topical lotions and creams. According to the agency, the companies made unsubstantiated claims about their products’ ability to prevent, reverse, or cure cancer; kill or inhibit cancer cells or tumors; or similar claims. Some products were also marketed as alternative or additional treatment for other serious diseases, including Alzheimer’s.